European LeukemiaNet criteria for safety and efficacy evaluation of new drugs for myelofibrosis

Related articles

1. From Toxicity to Immunity: Evaluating CAR‐T and Conventional Therapies in Multiple Myeloma Through QALY Outcomes

   This article has 2 authors:

   1. Guluzar Gulnur Itez
   2. Asuman Sunguroğlu

2. Development of A Scoring System via An Interpretable End-to-end Neural Network for Prognostic Stratification of Patients with Advanced Melanoma

   This article has 21 authors:

   1. Ruihao Huang
   2. Hao Zhu
   3. Yue Huang
   4. Hanrui Zhang
   5. Yuanfang Guan
   6. Menglun Wang
   7. Lixia Zhang
   8. Yutao Gong
   9. Hong Zhao
   10. Shiew-Mei Huang
   11. Issam Zineh
   12. Yuan Li Shen
   13. Ge Feng
   14. Steven Lemery
   15. Marc R. Theoret
   16. Lola Fashoyin-Aje
   17. Shenggang Wang
   18. Mo Tiwari
   19. James Zou
   20. Sebastian Thrun
   21. Qi Liu

3. Cytogenetics-based Clinical Trajectories in Patients with MRD Negativity Post Autologous Transplant for Multiple Myeloma

   This article has 23 authors:

   1. Saurabh Zanwar
   2. Estefania Gauto Mariotti
   3. Shaji Kumar
   4. Wilson Gonsalves
   5. Francis Buadi
   6. Suzanne HAYMAN
   7. Nadine Abdallah
   8. Moritz Binder
   9. Joselle Cook
   10. Angela Dispenzieri
   11. David Dingli
   12. Morie Gertz
   13. Taxiarchis Kourelis
   14. Nelson Leung
   15. Yi Lin
   16. Mustaqueem Siddiqui
   17. Ronald Go
   18. Eli Muchtar
   19. Rahma Warsame
   20. Dragan Jevremovic
   21. Robert KYLE
   22. Prashant Kapoor
   23. S. Vincent Rajkumar